Skip to content

Integrity Labs

3 viewers · 30d

Total raised

$15.0M

1 filing since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $15.0M
ROUNDS
1
INVESTORS
7
FOUNDED
2022
HQ
Reston, VA
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
3

AI overview

Updated

Integrity Laboratories, Inc. is a pioneering biotechnology company committed to revolutionizing the management of infectious diseases through high-complexity clinical diagnostics. By offering cutting-edge molecular diagnostic testing solutions, the company strives to enhance the speed and accuracy of infectious disease detection and treatment across the healthcare landscape.

What sets it apart

Integrity Laboratories stands out for its intercept PCR™ platform, which delivers rapid diagnostic results using non-invasive techniques.

Funding history

1 round
EquityMar 7, 2025 · $50K min
Form D
+$15.0M$15.0M total

Latest SEC filings

via EDGAR · CIK 0002061384
Form D · Mar 7, 2025View on EDGAR

Products

1 tracked

Intercept PCR™ Platform

Molecular Diagnostics

The intercept PCR™ platform is an advanced molecular diagnostic testing solution that facilitates same-day and next-day results for complex infectious diseases. Its non-invasive methodology streamlines the diagnostic process, significantly enhancing patient care.

  • Rapid turnaround times (STAT and next-day results)
  • High-fidelity testing with over 99% specificity
  • Ability to differentiate polymicrobial specimens
  • Integrated data and actionable analytics

Links

WebsiteSEC EDGAR filings